Robert A Mcburney, 67110 Fulkerson Rd, Zanesville, OH 43701
Robert Mcburney Phones & Addresses
110 Fulkerson Rd, South Zanesville, OH 43701 740-4524090 740-4500687
Zanesville, OH
Conesville, OH
Sebastian, FL
Palm Bay, FL
122 Shawmut Ave, Marlborough, MA 01752 508-2290950
Midlothian, VA
Nashport, OH
Southborough, MA
Mentions for Robert A Mcburney
Publications & IP owners
Us Patents
Methods Of Treatment Of Eye Trauma And Disorders
US Patent:
6358696, Mar 19, 2002
Filed:
Aug 9, 2000
Appl. No.:
09/635309
Inventors:
Robert N. McBurney - Newton MA, 02158
International Classification:
G01N 3353
US Classification:
435 72, 564238, 549288, 424427
Abstract:
Methods are provided for treatment of eye disorders and injury, including methods for treatment of reduced flow of blood or other nutrients to retinal tissue and/or optic nerve, methods for treatment of retinal ischemia and trauma and methods for treatment for optic nerve injury/damage.
Methods Of Treatment Of Eye Trauma And Disorders
US Patent:
6673557, Jan 6, 2004
Filed:
Jan 29, 2002
Appl. No.:
10/060101
Inventors:
Robert N. McBurney - Newton MA, 02466
International Classification:
G01N 3353
US Classification:
435 72, 564238, 549288, 424427
Abstract:
Methods are provided for treatment of eye disorders and injury, including methods for treatment of reduced flow of blood or other nutrients to retinal tissue and/or optic nerve, methods for treatment of retinal ischemia and trauma and methods for treatment for optic nerve injury/damage.
Methods For Performing Differential Capture Proteomics
US Patent:
2006009, May 11, 2006
Filed:
Jun 20, 2003
Appl. No.:
10/518771
Inventors:
Paul Stroobant - Natick MA, US
Robert McBurney - Natick MA, US
Robert McBurney - Natick MA, US
International Classification:
G01N 33/543
US Classification:
436518000
Abstract:
Disclosed herein are improved methods for identifying, isolating, and comparing proteins and other biomolecules differing between two biological samples using affinity chromatography and phage display techniques.
Biological Systems Analysis
US Patent:
2010005, Mar 4, 2010
Filed:
Nov 30, 2005
Appl. No.:
11/791400
Inventors:
Noubar Afeyan - Lexington MA, US
Aram Adourian - Woburn MA, US
Robert McBurney - Newton MA, US
Aram Adourian - Woburn MA, US
Robert McBurney - Newton MA, US
International Classification:
G06F 19/00
G06G 7/60
G06G 7/60
US Classification:
702 19, 703 11
Abstract:
Disclosed are methods for the practice of systems pharmacology, systems toxicology, and systems pathology using patterns, such as images, reflective of the biological state of subjects such as humans or experimental mammals. The patterns are generated from data obtained from one or more samples from one or more subjects by applying certain data treatment techniques, and are reflective of the biochemistry of the subjects. The patterns are used in drug selection and discovery, assessment of toxicity and drug efficacy, segmentation of populations, discovery of disease subtypes, as surrogate end points, in the assessment of therapeutic options, and for diagnosis and prognosis of disease.
Methods Of Increasing Sarcosine Levels For Treating Schizophrenia
US Patent:
2011003, Feb 10, 2011
Filed:
Sep 18, 2008
Appl. No.:
12/678614
Inventors:
Robert Nicholas McBurney - Newton MA, US
Assignee:
BG MEDICINE, INC. - Waltham MA
International Classification:
A61K 31/195
A61K 31/216
A61K 31/192
A61P 25/18
A61K 31/216
A61K 31/192
A61P 25/18
US Classification:
514533, 514543, 514571, 514563
Abstract:
Methods for increasing sarcosine levels in a patient are provided. The methods include activating the PPARα receptor. Increasing sarcosine levels can be used, for example, as part of a treatment for schizophrenia.
Assessing Congestive Heart Risk In Patients Treated Or Potentially To Be Treated With A Peroxisome-Proliferator-Activator-Receptor-Gamma Agonist Or A Thiazolidinedione
US Patent:
2011004, Feb 24, 2011
Filed:
Sep 16, 2008
Appl. No.:
12/678408
Inventors:
Robert Nicholas McBurney - Newton MA, US
Shunguang Wang - Carlisle MA, US
Tom Plasterer - Marlboro MA, US
Pieter Muntendam - Boxford MA, US
Shunguang Wang - Carlisle MA, US
Tom Plasterer - Marlboro MA, US
Pieter Muntendam - Boxford MA, US
Assignee:
BG MEDICINE, INC. - Waltham MA
International Classification:
A61K 31/4439
C12Q 1/02
A61P 9/04
G01N 33/50
A61K 31/18
A61K 31/155
C12Q 1/02
A61P 9/04
G01N 33/50
A61K 31/18
A61K 31/155
US Classification:
514342, 435 29, 436 86, 514593, 514635
Abstract:
Methods are provided for assessing a patient being treated with a peroxisome-proliferator-activator-receptor-γ (PPAR-γ) agonist or a thiazolidinedione (TZD), or having a condition treatable with a peroxisome-proliferator-activator-receptor-γagonist or a thiazolidinedione. Methods include measuring a galectin-3 concentration or a change in a galectin-3 concentration in a body fluid of a patient being treated with a peroxisome-proliferator-activator-receptor-γ agonist or a thiazolidinedione. A comparison to galectin-3 levels or changes in comparable patients provides information indicative of congestive heart risk.
Methods Of Treatment Of Eye Trauma And Disorders
US Patent:
6242198, Jun 5, 2001
Filed:
Jul 25, 1996
Appl. No.:
8/686494
Inventors:
Robert N. McBurney - Newton MA
Assignee:
Cambridge Neuroscience, Inc. - Cambridge MA
International Classification:
G01N 3353
C07C27700
C07D31102
A61F 200
C07C27700
C07D31102
A61F 200
US Classification:
435 72
Abstract:
Methods are provided for treatment of eye disorders and injury, including methods for treatment of reduced flow of blood or other nutrients to retinal tissue and/or optic nerve, methods for treatment of retinal ischemia and trauma and methods for treatment for optic nerve injury/damage.
NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.